UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DOP02 Developing explicit thresholds for outcomes to inform (GRADE) Evidence to Decision frameworks for Inflammatory Bowel Disease guidelines

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i73-i74

2024

Volltextzugriff (PDF)

P242 Universal exclusion of patients with Permanent Ileostomy in Crohn’s disease clinical trials: A systematic review

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i394-i395

2023

Volltextzugriff (PDF)

P390 Adiposity is negatively associated with a stenosing Crohn’s disease behaviour: a UK wide study in 8797 patients within the IBD Bioresource

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i818-i819

2024

Volltextzugriff (PDF)

P1043 Immunomodulator and advanced therapies for prevention of clinical relapse and loss of response during maintenance phase in Crohn’s disease: A systematic review and network meta-analysis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1881-i1881

2024

Volltextzugriff (PDF)

P556 Immunomodulator and advanced therapies for Induction of clinical remission and response in Crohn’s disease: A systematic review and network meta-analysis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1092-i1092

2024

Volltextzugriff (PDF)

P756 Efficacy and safety of medical therapies for maintenance of surgically induced remission in Crohn’s disease: A systematic review and network meta-analysis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1410-i1410

2024

Volltextzugriff (PDF)

P972 Short and long-term outcomes after acute severe ulcerative colitis in children: A Canadian single centre experience

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1763-i1764

2024

Volltextzugriff (PDF)

P550 Short and long-term outcomes after acute severe ulcerative colitis in adults: A 12 year Canadian experience in the post biologic era

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1082-i1083

2024

Volltextzugriff (PDF)

P882 A Phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1625-i1625

2024

Volltextzugriff (PDF)

P002 Exclusive Enteral Nutrition, the gut microbiome and corticosteroid response in patients with acute severe colitis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i170-i171

2023

Volltextzugriff (PDF)

P720 Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i614-i615

2022

Volltextzugriff (PDF)

P546 Minimal risk of lymphoma despite long term use of azathioprine in patients with Inflammatory Bowel Disease: a longitudinal cohort analysis from Northern India

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i493-i494

2022

Volltextzugriff (PDF)

P709 Distinct Pattern of Gut Microbial Dysbiosis in Crohn’s Disease and Intestinal Tuberculosis - A Machine Learning-based classification model

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i606-i607

2022

Volltextzugriff (PDF)

P716 Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i611-i612

2022

Volltextzugriff (PDF)

P301 Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i330-i331

2022

Volltextzugriff (PDF)

P1041 Coconut water modulates dietary potassium and gut microbiome to induce remission in ulcerative colitis: randomized controlled trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1877-i1877

2024

Volltextzugriff (PDF)

P635 Intravenous albumin infusion does not augment the response rate to a combination of exclusive enteral nutrition and intravenous steroids in Acute Severe Ulcerative Colitis: a randomized controlled trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1218-i1218

2024

Volltextzugriff (PDF)

P338 Long-term complications in patients with fistulising Crohn’s disease

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S271-S271

2019

Volltextzugriff (PDF)

P702 Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative Colitis

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i598-i601

2022

Volltextzugriff (PDF)

P418 Development and validation of a digital health platform (IBD NutriCare) for telenutrition in patients with Inflammatory bowel disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i407-i407

2022

Volltextzugriff (PDF)

P423 Azathioprine still remains the first step-up therapy in patients with Inflammatory Bowel Disease in low-middle income countries

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i409-i410

2022

Volltextzugriff (PDF)

P531 Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i484-i484

2022

Volltextzugriff (PDF)

Narasimham Committee Report-Some Further Ramifications And Suggestions

Paripex - Indian Journal Of Research, 2012-01, Vol.3 (1), p.37-40

Venkateswarlu, Kasetti

2012

Volltextzugriff (PDF)

Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients

Journal of rheumatology, 1996-06, Vol.23 (6), p.1005

1996

Volltextzugriff (PDF)

Slew efficiency plays primary role in op-amp selection

EDN, 2004-03, Vol.49 (6), p.77-78

Vuyyuru, Sameer

2004

Volltextzugriff (PDF)

1 – 25 von 410

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(290)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(408)
Deutsch
(3)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(160)
Life Sciences & Biomedicine
(110)
Gastroenterology & Hepatology
(56)
Humans
(45)
Technology
(42)
Engineering
(25)
Computer Science
(24)
Animals
(22)
Inflammatory Bowel Disease
(21)
Ulcerative Colitis
(21)
Patients
(20)
Accuracy
(19)
Algorithms
(19)
Engineering, Electrical & Electronic
(19)
Machine Learning
(19)
Care And Treatment
(16)
Gastroenterology
(16)
Male
(16)
Medicine
(16)
Medicine & Public Health
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

DOP02 Developing explicit thresholds for outcomes to inform (GRADE) Evidence to Decision frameworks for Inflammatory Bowel Disease guidelines

P242 Universal exclusion of patients with Permanent Ileostomy in Crohn’s disease clinical trials: A systematic review

P390 Adiposity is negatively associated with a stenosing Crohn’s disease behaviour: a UK wide study in 8797 patients within the IBD Bioresource

P1043 Immunomodulator and advanced therapies for prevention of clinical relapse and loss of response during maintenance phase in Crohn’s disease: A systematic review and network meta-analysis

P556 Immunomodulator and advanced therapies for Induction of clinical remission and response in Crohn’s disease: A systematic review and network meta-analysis

P756 Efficacy and safety of medical therapies for maintenance of surgically induced remission in Crohn’s disease: A systematic review and network meta-analysis

P972 Short and long-term outcomes after acute severe ulcerative colitis in children: A Canadian single centre experience

P550 Short and long-term outcomes after acute severe ulcerative colitis in adults: A 12 year Canadian experience in the post biologic era

P882 A Phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease

P002 Exclusive Enteral Nutrition, the gut microbiome and corticosteroid response in patients with acute severe colitis

P720 Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls

P546 Minimal risk of lymphoma despite long term use of azathioprine in patients with Inflammatory Bowel Disease: a longitudinal cohort analysis from Northern India

P709 Distinct Pattern of Gut Microbial Dysbiosis in Crohn’s Disease and Intestinal Tuberculosis - A Machine Learning-based classification model

P716 Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis

P301 Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease

P1041 Coconut water modulates dietary potassium and gut microbiome to induce remission in ulcerative colitis: randomized controlled trial

P635 Intravenous albumin infusion does not augment the response rate to a combination of exclusive enteral nutrition and intravenous steroids in Acute Severe Ulcerative Colitis: a randomized controlled trial

P338 Long-term complications in patients with fistulising Crohn’s disease

P702 Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative Colitis

P418 Development and validation of a digital health platform (IBD NutriCare) for telenutrition in patients with Inflammatory bowel disease

P423 Azathioprine still remains the first step-up therapy in patients with Inflammatory Bowel Disease in low-middle income countries

P531 Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region

Narasimham Committee Report-Some Further Ramifications And Suggestions

Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients

Slew efficiency plays primary role in op-amp selection

Suchergebnisse filtern